Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series

BACKGROUND: Polypharmacy can complicate the course and management of chronic diseases, and has been little explored in patients with inflammatory bowel disease (IBD) to date. AIM: The aim of this study was to determine the prevalence of polypharmacy in a series of IBD patients, describing associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesonero, Francisco, Fernández, Cristina, Sánchez-Rodríguez, Eugenia, García-García Paredes, Ana, Senosiain, Carla, Albillos, Agustín, López-Sanromán, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Online Articles: Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843391/
https://www.ncbi.nlm.nih.gov/pubmed/34864790
http://dx.doi.org/10.1097/MCG.0000000000001647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843391/
https://www.ncbi.nlm.nih.gov/pubmed/34864790
http://dx.doi.org/10.1097/MCG.0000000000001647

Ejemplares similares